Canada Pension Plan Investment Board
CHRS icon

Canada Pension Plan Investment Board’s Coherus Oncology CHRS Stock Holding History

Canada Pension Plan Investment Board’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-73,900
Closed -$1.32M – 1143
2020
Q2 		$1.32M Buy
+73,900
New +$1.25M ﹤0.01% 856

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Canada Pension Plan Investment Board's CHRS Position: Q3 2020 in Review

Canada Pension Plan Investment Board sold out of Coherus Oncology (CHRS) in Q3 2020, closing a stake of 73,900 shares — an estimated $1.32M sold.

Canada Pension Plan Investment Board first reported a position in CHRS in Q2 2020 and held it in 1 quarter. The position peaked at $1.32M in Q2 2020. 201 funds tracked by Wall St. Rank hold CHRS as of Q3 2020.

  • Canada Pension Plan Investment Board reported no remaining Coherus Oncology position as of Q3 2020 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 73,900 Coherus Oncology shares in Q3 2020, an estimated $1.32M.
  • Canada Pension Plan Investment Board first reported a position in Coherus Oncology in Q2 2020 and held it in 1 quarter.
  • Canada Pension Plan Investment Board's Coherus Oncology position peaked at $1.32M in Q2 2020.
  • 201 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2020.

Based on Canada Pension Plan Investment Board's 13F filing for Q3 2020, filed 12 Nov 2020.